| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3199194 | Journal of Allergy and Clinical Immunology | 2011 | 8 Pages |
Abstract
HSCT is a successful treatment for patients with CD3δ deficiency. The small number of patients in this report prevents definitive statements on the importance of survival factors, but several are suggested: (1) HLA-matched donor transplants are associated with superior reconstitution and survival than are mismatched donor transplants; (2) substantial conditioning appears necessary; and (3) early diagnosis and absence of opportunistic infections may affect outcome.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Nufar MD, Hidetoshi MD, Jason MD, Morton J. MD, Juana MD, PhD, Jose R. MD, PhD, Diego MD, Eduardo MD, PhD, Jignesh MD, Wilhelm MD, Hoenig MD, Imelda Celine MD, Eyal MD, William T. MD, PhD, Chaim M. MD, FRCPC,